Anaesthesia Decision Support - Dräger SmartPilot View

Anaesthesia Decision Support

• •Calculates and predicts the combined effects of commonly used analgesic and hypnotic drugs.
• •Supports the clinician in intraoperatively administering drugs in a patient-individualized and optimized manner

Highlights

The software estimates and visualises complex interactions of anaesthetic drugs based on pharmacodynamic modelling for both the current and predicted course of anaesthesia. SmartPilot View supports informed decision-making that facilitates more precision and individualisation in anaesthetic drugs titration. Based on clinical evidence, SmartPilot View can help to minimise the total amount of consumed drugs.

Support decision-making

SmartPilot View supports the decision-making by turning complex pharmacokinetic and pharmacodynamic calculations into an easy-to-interpret visualisation of

• •Current anaesthesia level and hypnotic-analgesic balance
• •20 minute prediction of the anaesthesia level
• •Built-in pre-prediction ("What if..." function) for IV pump rates and anaesthesia device settings that shows what effect a rate change or bolus would have
• •Numeric value of anaesthesia level (Noxious Stimulus Response Index - NSRI)

Optimise OR and PACU utilisation

SmartPilot View may help to optimise OR and PACU utilisation times with:

• •Bar graph indicator to estimate patient wake-up time
• •Individualised drug dosing to reduce risk of overdosing that may help to mitigate prolonged PACU stays

Provide comprehensive visualisation

SmartPilot View provides instant access to the status of anaesthesia and the administered drugs throughout the entire surgical procedure to support the intuitive and rapid assessment of the patient's status with:

• •Isobole lines on 2D diagram representing areas of probability how patient will react to a defined pain stimulus, and indicating the level of anaesthesia (e.g. TOL 90, TOL 50, TOSS 50, MAC 50)
• •History function on the 2D diagram to track the anaesthesia level from the beginning of the case
• •Effect-site concentrations displayed as numeric values and trends
• •Calculated effect-site concentrations of administered hypnotics, opioids, and muscle relaxants for past (40 minutes), present, and preview (20 minutes) periods
• •Optional: Selected vital parameters, including heart rate, blood pressure and CO2, and BIS